AzTrials
AzTrials

Functional RecoveryNCT03870698

Comparison of Functional Recovery Between Laparoscopic and Open Pancreaticoduodenectomy

A study testing Laparoscopic group in people with Functional Recovery and Laparoscopy, run by Asan Medical Center at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Laparoscopic surgery has not changed much in safety compared with open surgery through many existing studies, and has become a procedure to help patients' recovery. Recently, laparoscopic surgery has been actively performed for pancreaticoduodenectomy, one of the most complicated procedures in intraperitoneal surgery. Read more about this study

Who is it for?
Ages 19 to 80 yearsHealthy volunteers can take part
What is being tested?
Laparoscopic group
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
252 participants
Where
1 siteSouth Korea
Study dates
9 May 2019to 31 Aug 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age: 19 to 80 years
  • Performance: Eastern Cooperative Oncology Group (ECOG) 0-2
  • The preoperative examination showed that the lesion could not be invaded by major blood vessels.
  • No distant metastasis
  • Bone marrow function: white blood cell (WBC) at least 3,000 / mm3, Platelet count at least 100,000 / mm3
  • Kidney function: Creatinine no greater than 1.5 times upper limit of normal.
  • Patients who consented to and signed the consent

Who cannot join

  • Severe obesity (BMI> 30)
  • Those with active or uncontrolled infections
  • Those with severe psychiatric / neurological disorders
  • Alcohol or other drug addicts
  • Patients included in other clinical studies that may affect this study
  • Patients who cannot follow the directions of the researcher
Show all 11Show fewer
  • Those with uncontrolled heart disease
  • Patients with moderate or severe comorbidities who are thought to have an impact on quality of life or nutritional status (cirrhosis, chronic kidney failure, heart failure, etc.)
  • Pelvic tumor, benign tumor, malignant tumor in other organs
  • Patients who received prior chemotherapy
  • In addition to the planned PD patients who require resection of other major abdominal organs (such as gastrectomy, colonic resection and portal / upper mesenteric vascular resection, more than standard PD)

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Asan medical center

    Seoul, 05505

Other trials in South Korea

About this study

Official title: Comparison of Perioperative Outcomes Between Laparoscopic and Open Pylorus Preserving Pancreaticoduodenectomy in Periampullary Tumors: Randomized Controlled Study

Laparoscopic surgery has not changed much in safety compared with open surgery through many existing studies, and has become a procedure to help patients' recovery.

Recently, laparoscopic surgery has been actively performed for pancreaticoduodenectomy, one of the most complicated procedures in intraperitoneal surgery.

Read more

the investigators will perform a prospective study to establish a higher level of evidence for the efficacy and safety of laparoscopic pancreaticoduodenectomy.

The purpose of this study was to compare the short-term clinical outcomes including the functional recovery after surgery, complications and confirm that laparoscopic pancreaticoduodenectomy is safe and appropriate. This study includes an interim analysis and can be terminated early by analysis at the completion of 50% of planned patients.

Read the detailed description
  • Pancreatoduodenectomy is a standard procedure for periampullary disease of the duodenum (pancreatic cancer, biliary pancreatic cancer, bile duct cancer, etc.) and is a very extensive and complicated operation for partial resection of the pancreas, duodenum, bile duct, gallbladder and occasionally stomach. In addition, anastomotic anastomoses are considered to be one of the most complicated surgeries among intraperitoneal procedures, even in open surgery. Laparoscopic surgery has been advancing rapidly with the development of the technique of laparoscopic surgery. In recent years, Pancreatoduodenectomy has been actively attempting laparoscopic surgery centering on large organs. As a result, large incision and abdominal wall traction can be avoided. Common advantages include postoperative pain relief, rapid recovery of bowel movements, fewer days of hospitalization, and a quick return to daily life. In addition, recently reported meta-analysis has shown that laparoscopic Pancreatoduodenectomy has a significantly lower bleeding volume and duration of hospitalization compared to open surgery.
  • This study was aimed to compared functional recovery between open and laparoscopic PD in 3 tertiary referral centers in Korea. The investigators will measure functional recovery .
  • A case of pancreaticoduodenectomy with benign tumor in the pancreas will be included. The expected number of patients is 252. The laparoscopic surgery was performed in the experimental group and the open surgery was performed in the control group. When achieving 50% of the planned target group, the interim analysis will decide whether to continue the study.

This clinical study is a randomized prospective comparative study of the outcome of laparoscopic and open Pancreatoduodenectomy, and the research hypothesis is as follows.

  • Nursing Hypothesis: There is no difference in the functional recovery between patients who underwent laparoscopic pancreaticoduodenectomy and patients who underwent open surgery.
  • Alternative Hypothesis: Based on the results of the same operation of the existing institution, the average functional recovery for open pancreaticoduodenectomy is estimated to be 14 days, and the functional recovery for laparoscopic pancreaticoduodenectomy is reduced by 20%.

The random assignment of this study is assigned according to the order of assignment in the planning stage of the study as a block randomization scheme with appropriate block size set.

  • Plan for recruitment of research subjects All patients who underwent pancreaticoduodenectomy for the pancreas or peripapillary lesion were selected and selected as subjects after explaining the study and accepting consent.
  • Operative methods Both patients underwent conventional pancreaticoduodenectomy or pyloric preservation pancreaticoduodenectomy. In the control group, the midline incision was performed and the operation was performed by the laparotomy. In the experimental group, laparoscopic surgery was performed using 5-6 trocars. Laparoscopy and laparotomy are performed through the same surgical procedure and the procedure is as follows. Kocher maneuver is performed to mobilize the duodenum.

Omentectomy is performed and the gastrocolic truck is identified and ligated. The stomach or duodenum is cut off using an automatic stapler. A cholecystectomy is performed. The bile duct is cut and the frozen section is checked to confirm whether the tumor is invaded. The hepatic and hepatic arteries are dissected and the surrounding lymph nodes are dissected. The gastroduodenal artery is detached and ligated. The pancreas is cut from the pancreas neck, and the tumor is examined by freezing biopsy. The proximal plant is dissected and cut, and the pancreas uncinate process is released from the superior mesenteric artery and vein. Pancreaticojejunal anastomosis, hepaticojejunal anastomosis, gastrojejunal or duodenojejunal anastomosis are performed. In this case, anastomosis is performed by the method used by each institution.

Indications for open conversion

  • In a situation where the safety of the patient is threatened, it is possible to switch to the opener at any time under the judgment of the researcher.
  • Vascular involvement of the superior mesenteric vein, superior mesenteric artery, and hepatic artery is suspected and the operation is difficult to perform.
  • The operation is difficult due to severe pancreatitis
  • Laparoscopic treatment is difficult if there is bleeding

Patient management after surgery.

  • 1 day after surgery: Removal of blood and nasogastric tube after surgery, water intake, early gait, cytokine check
  • 2 days after surgery: initiation or death, cytokine check
  • 3 days after surgery: intravenous patient controlled analgesia removal, after 3 days, considering drain amylase and drain volume can be removed. Check functional recovery daily after 3 days
  • 5 days after surgery: Perform computed tomography.
  • 7 days after surgery: If the patient is a malignant tumor, the tumor marker will be collected. Cytokine check
Being tested
Laparoscopic group

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Laparoscopic groupProcedure or surgery

    The patients in laparoscopic group will underwent pylorus preserving pancreaticoduodenectomy in laparoscopic manners.

Study groups in NCT03870698
Study groupRoleWhat they receive
Laparoscopic groupExperimentalThe patients who underwent laparoscopic procedures for periampullary tumors
Receives: Procedure: Laparoscopic group
Open groupNo interventionThe patients who underwent open procedures for periampullary tumors

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time to functional recovery after surgery

    It is defined that functional recovery is achieved if all of the following are satisfied.

    1. Pain can be controlled by oral or patch analgesic without intravenous analgesics. * 2. Free walking (modified enhanced recovery after surgery mobility scale 5/5) ** 3. Free diet is available (more than 1/2 of the dietary intake) 4. No evidence of infection (body temperature <38.5 degrees, C-reactive protein (CRP) 15 mg / dL, no complicated fluid collection on postoperative computed tomography 5. There should be no intravenous injection .

    Measured: up to 1 months

Secondary outcomes (7)
  1. Numbers of Hospital stay

    It is defined that discharge day after surgery

    Measured: up to 2 months

  2. Minutes of operation time

    It mean time from anesthesia to end of surgery

    Measured: Up to 1 day after surgery

  3. amount of estimated blood loss

    It means amount of bleeding during surgery

    Measured: up to 1 day after surgery

  4. Severity of postoperative pain

    It refers to the degree of pain measured during 2 days after surgery

    Measured: Up to 3 days

  5. postoperative complications

    It means all kinds of complications after surgery

    Measured: up to 2 months

  6. Numbers of complete resection in pathological results

    It means no remnant tumor in pathologic results

    Measured: Up to 2weeks

  7. level of serum cytokine

    It means value of serum cytokine, which was collected after surgery

    Measured: Up to 1 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Mar 2019
  2. Study start9 May 2019
  3. Primary completion10 Jun 2022
  4. Study completion31 Aug 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
252 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03870698
Sponsor's protocol ID
CORLAPPD_01
Status last verified
Feb 2023
First submitted
6 Mar 2019
Last updated
27 Feb 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Yoon YS, Lee W, Kang CM, Hong T, Shin SH, Lee JW, Hwang DW, Song KB, Kwon JW, Sung MK, Shim IK, Lee JB, Kim SC; for Korean Study Group on Minimally Invasive Pancreatic Surgery (K-MIPS). Laparoscopic versus open pancreatoduodenectomy for periampullary tumors: a randomized clinical trial. Int J Surg. 2024 Nov 1;110(11):7011-7019. doi: 10.1097/JS9.0000000000002035.

    PubMed 39172725

Questions about this trial

What is this clinical trial studying?

A study testing Laparoscopic group in people with Functional Recovery and Laparoscopy, run by Asan Medical Center at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time to functional recovery after surgery (time frame: up to 1 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03870698, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Feb 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in